Meritage Homes
MTH
Amazon
AMZN
Strategy
MSTR
4
Salesforce
CRM
5
Meta Platforms
META
US Stock MarketDetailed Quotes
XFOR X4 Pharmaceuticals
- 3.240
- +0.020+0.62%
Close May 7 16:00 ET
18.76MMarket Cap1.54P/E (TTM)
3.410High3.210Low119.07KVolume3.320Open3.220Pre Close393.52KTurnover2.71%Turnover RatioLossP/E (Static)5.79MShares33.90052wk High0.82P/B14.25MFloat Cap3.05052wk Low--Dividend TTM4.40MShs Float717.900Historical High--Div YieldTTM6.21%Amplitude3.050Historical Low3.304Avg Price1Lot Size
X4 Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 63.19%-12.37M | -35.63%-130.9M | -18.91%-33M | -63.40%-34.03M | -41.32%-30.28M | -26.72%-33.6M | -25.17%-96.51M | -45.33%-27.75M | -7.88%-20.83M | -15.97%-21.43M |
| Net income from continuing operations | 100.54%282K | 62.98%-37.45M | -108.16%-39.82M | -1,492.02%-36.7M | 263.04%90.83M | -115.51%-51.77M | -7.78%-101.17M | 34.27%-19.13M | 89.32%-2.31M | -162.64%-55.71M |
| Operating gains losses | -178.74%-10.83M | -1,411.56%-106.93M | 142.14%2.67M | 107.41%1.86M | -519.34%-125.22M | 352.90%13.76M | -345.54%-7.07M | ---6.33M | ---25.16M | --29.86M |
| Depreciation and amortization | 667.74%476K | 89.98%796K | 340.32%273K | 156.73%267K | 53.97%194K | -51.18%62K | -18.32%419K | -50.00%62K | -16.13%104K | -4.55%126K |
| Other non cash items | -11.09%465K | -20.93%1.8M | 0.21%472K | -41.51%372K | -29.04%435K | -6.44%523K | -6.44%2.28M | 11.08%471K | -45.87%636K | 55.98%613K |
| Change In working capital | -256.94%-3.28M | 677.62%2.68M | 122.32%1.2M | -146.86%-1.66M | -32.21%1.05M | 239.29%2.09M | -94.00%344K | -197.86%-5.36M | 2,823.08%3.54M | 123.73%1.55M |
| -Change in receivables | --561K | ---1.07M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Change in inventory | ---272K | ---2.82M | ---372K | ---1.61M | ---831K | --0 | --0 | --0 | --0 | ---- |
| -Change in prepaid assets | -81.07%201K | 149.85%683K | 71.90%-514K | -905.00%-201K | 120.93%336K | -49.04%1.06M | -124.59%-1.37M | -138.15%-1.83M | 96.98%-20K | -97.66%-1.61M |
| -Change in payables and accrued expense | -518.45%-5.31M | 142.19%6.88M | 205.56%3.42M | -89.37%411K | -47.80%1.79M | 204.11%1.27M | -60.68%2.84M | -150.52%-3.24M | 397.17%3.87M | 96.62%3.43M |
| -Change in other current liabilities | -14.17%-274K | 10.99%-1M | 10.54%-263K | 17.21%-255K | 10.87%-246K | 4.00%-240K | -27.89%-1.13M | -82.61%-294K | -25.71%-308K | -15.00%-276K |
| -Change in other working capital | --1.81M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 63.19%-12.37M | -35.63%-130.9M | -18.91%-33M | -63.40%-34.03M | -41.32%-30.28M | -26.72%-33.6M | -25.17%-96.51M | -45.33%-27.75M | -7.88%-20.83M | -15.97%-21.43M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 41.04%-3.14M | 550.11%66.99M | -78.38%-8.62M | -208.88%-15.93M | 2,083.25%96.86M | -59,033.33%-5.32M | -14,349.51%-14.88M | -14,114.71%-4.83M | -57,200.00%-5.16M | -12,752.63%-4.88M |
| Net PPE purchase and sale | --0 | -443.33%-326K | -17.14%-41K | -1,050.00%-92K | -1,575.00%-134K | -555.56%-59K | 41.75%-60K | -2.94%-35K | 11.11%-8K | 78.95%-8K |
| Net intangibles purchase and sale | ---3M | ---7M | --0 | --0 | ---7M | --0 | --0 | --0 | --0 | ---- |
| Net investment purchase and sale | 97.38%-138K | -107.00%-30.68M | -78.82%-8.58M | -207.57%-15.84M | 79.41%-1M | ---5.26M | ---14.82M | ---4.8M | ---5.15M | ---4.88M |
| Net other investing changes | ---- | --105M | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 41.04%-3.14M | 550.11%66.99M | -78.38%-8.62M | -208.88%-15.93M | 2,083.25%96.86M | -59,033.33%-5.32M | -14,349.51%-14.88M | -14,114.71%-4.83M | -57,200.00%-5.16M | -12,752.63%-4.88M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -77.07%20.29M | 39.18%135K | 0 | -70.93%20.16M | 0 | -24.49%88.52M | -99.84%97K | -59.20%21.21M | 20,082.13%69.34M | |
| Net issuance payments of debt | ---- | -2.13%20M | --0 | --0 | 5,149.34%20M | --0 | 2,670.57%20.44M | --0 | 4,851.25%21.74M | 217.23%381K |
| Net common stock issuance | ---- | --0 | 98.15%-159K | -98.09%159K | --0 | --0 | -51.07%60M | -113.89%-8.62M | -84.79%8.33M | 276,122.73%60.73M |
| Proceeds from stock option exercised by employees | ---- | -96.63%294K | ---- | ---- | ---- | ---- | 4,088.46%8.71M | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | 86.89%-631K | --0 | ---250K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -77.07%20.29M | 39.18%135K | --0 | -70.93%20.16M | --0 | -24.49%88.52M | -99.84%97K | -59.20%21.21M | 20,082.13%69.34M |
| Net cash flow | ||||||||||
| Beginning cash position | -43.66%56.48M | -18.52%100.25M | -25.94%98.2M | 7.67%148M | -35.12%61.27M | -18.52%100.25M | 48.03%123.03M | 63.41%132.6M | 182.35%137.46M | 39.40%94.43M |
| Current changes in cash | 60.16%-15.51M | -90.64%-43.62M | -27.70%-41.48M | -945.21%-49.96M | 101.59%86.74M | -35.87%-38.92M | -157.16%-22.88M | -178.24%-32.48M | -114.63%-4.78M | 328.16%43.03M |
| Effect of exchange rate changes | 222.03%72K | -257.58%-156K | -292.13%-244K | 329.17%165K | -200.00%-18K | -218.00%-59K | 194.29%99K | -65.01%127K | 63.45%-72K | 97.03%-6K |
| End cash Position | -33.02%41.04M | -43.66%56.48M | -43.66%56.48M | -25.94%98.2M | 7.67%148M | -35.12%61.27M | -18.52%100.25M | -18.52%100.25M | 63.41%132.6M | 182.35%137.46M |
| Free cash flow | 54.34%-15.37M | -43.13%-138.23M | -18.91%-33.04M | -63.77%-34.12M | -74.55%-37.41M | -26.90%-33.66M | -25.09%-96.57M | -45.25%-27.78M | -7.87%-20.84M | -15.78%-21.43M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call